Health
Scientists find a surprising clue to why GLP-1 drugs work so well
Yale researchers found that semaglutide appears to activate — rather than suppress — brain cells normally associated with hunger
News about healthcare, drugs and all the supposed "wellness" flimflam.
Health
Yale researchers found that semaglutide appears to activate — rather than suppress — brain cells normally associated with hunger
Health
The Department of Veterans Affairs is launching a large Phase 3 trial of semaglutide as a treatment for alcohol use disorder.
Insurance
Health coverage is becoming another fixed expense that households are forced to reconsider.
Health
Advocates fear weaker federal enforcement — combined with deep Medicaid funding reductions — could make community-based care an easier target for state budget cuts.
Insurance
Heads up! A federal subsidy for Medicare Part D is ending. Your premium may be affected.
Insurance
The federal government will end a temporary program that has held down premiums for stand-alone Medicare Part D drug plans
Health
A string of negative news is reflected in a sinking consumer confidence rating.
Health
The proposed settlement would resolve nearly all remaining lawsuits alleging Johnson & Johnson’s talc-based powders caused ovarian cancer.
Health
The outbreak touches nearly the entire United States, extending to 41 states at last count.
Health
An FDA advisory committee recommended allowing compounding pharmacies to make six popular peptides promoted for healing, weight control, endurance and anti-aging.
Health
A large study found that people taking GLP-1 drugs were more likely to be diagnosed with hair loss than patients using two other common classes of diabetes medication.
Health
A federal magistrate judge has ordered thousands of ovarian-cancer plaintiffs to explain how they can prove that Johnson & Johnson talc caused each woman’s illness.